EP0960120A4 - GENE MAMMALIEN (Scm) A EFFET ONCOGENE - Google Patents

GENE MAMMALIEN (Scm) A EFFET ONCOGENE

Info

Publication number
EP0960120A4
EP0960120A4 EP97924583A EP97924583A EP0960120A4 EP 0960120 A4 EP0960120 A4 EP 0960120A4 EP 97924583 A EP97924583 A EP 97924583A EP 97924583 A EP97924583 A EP 97924583A EP 0960120 A4 EP0960120 A4 EP 0960120A4
Authority
EP
European Patent Office
Prior art keywords
mammalian
midleg
oncogene
acts
scm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97924583A
Other languages
German (de)
English (en)
Other versions
EP0960120A1 (fr
Inventor
Filippo Randazzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of EP0960120A1 publication Critical patent/EP0960120A1/fr
Publication of EP0960120A4 publication Critical patent/EP0960120A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4745Cancer-associated SCM-recognition factor, CRISPP
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
EP97924583A 1996-05-06 1997-05-06 GENE MAMMALIEN (Scm) A EFFET ONCOGENE Withdrawn EP0960120A4 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US1687696P 1996-05-06 1996-05-06
US16876P 1996-05-06
US1729496P 1996-05-13 1996-05-13
US17294P 1996-05-13
US2045096P 1996-06-18 1996-06-18
US20450P 1996-06-18
US3299496P 1996-12-16 1996-12-16
US32994P 1996-12-16
US3509097P 1997-01-14 1997-01-14
US35090P 1997-01-14
PCT/US1997/007574 WO1997042218A1 (fr) 1996-05-06 1997-05-06 GENE MAMMALIEN Scm A EFFET ONCOGENE

Publications (2)

Publication Number Publication Date
EP0960120A1 EP0960120A1 (fr) 1999-12-01
EP0960120A4 true EP0960120A4 (fr) 2001-05-02

Family

ID=27533705

Family Applications (2)

Application Number Title Priority Date Filing Date
EP97924583A Withdrawn EP0960120A4 (fr) 1996-05-06 1997-05-06 GENE MAMMALIEN (Scm) A EFFET ONCOGENE
EP97926403A Withdrawn EP0915904A4 (fr) 1996-05-06 1997-05-06 GENE MAMMALIEN (Scm) A EFFET SUPPRESSEUR DE TUMEUR

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP97926403A Withdrawn EP0915904A4 (fr) 1996-05-06 1997-05-06 GENE MAMMALIEN (Scm) A EFFET SUPPRESSEUR DE TUMEUR

Country Status (4)

Country Link
EP (2) EP0960120A4 (fr)
JP (2) JP2000510693A (fr)
AU (2) AU2996797A (fr)
WO (2) WO1997042218A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0960120A4 (fr) * 1996-05-06 2001-05-02 Chiron Corp GENE MAMMALIEN (Scm) A EFFET ONCOGENE
AU757478C (en) * 1998-03-31 2004-03-25 Genzyme Corporation Compositions and methods for the identification of lung tumor cells
US6203989B1 (en) 1998-09-30 2001-03-20 Affymetrix, Inc. Methods and compositions for amplifying detectable signals in specific binding assays

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016178A2 (fr) * 1992-02-12 1993-08-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences caracteristiques du produit de transcription des genes humains
WO1997042211A1 (fr) * 1996-05-06 1997-11-13 Chiron Corporation GENE MAMMALIEN Scm A EFFET SUPPRESSEUR DE TUMEUR

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016178A2 (fr) * 1992-02-12 1993-08-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences caracteristiques du produit de transcription des genes humains
WO1997042211A1 (fr) * 1996-05-06 1997-11-13 Chiron Corporation GENE MAMMALIEN Scm A EFFET SUPPRESSEUR DE TUMEUR

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BORNEMANN DOUGLAS ET AL: "The Drosophila Polycomb group gene Sex comb on midleg (Scm) encodes a zinc finger protein with similarity to polyhomeotic protein.", DEVELOPMENT (CAMBRIDGE), vol. 122, no. 5, 1996, pages 1621 - 1630, XP002161672, ISSN: 0950-1991 *
NOMURA M ET AL: "ISOLATION AND CHARACTERIZATION OF REINOIC ACID-INDUCIBLE CDNA CLONES IN F9 CELLS: ONE OF THE EARLY INDUCIBLE CLONES ENCODES A NOVEL PROTEIN SHARING SEVERAL HIGHLY HOMOLOGOUS REGIONS WITH A DROSOPHILA POLYHOMEOTIC PROTEIN", DIFFERENTIATION,DE,SPRINGER VERLAG, vol. 57, no. 1, 1 June 1994 (1994-06-01), pages 39 - 50, XP002046787, ISSN: 0301-4681 *
See also references of WO9742218A1 *

Also Published As

Publication number Publication date
WO1997042218A1 (fr) 1997-11-13
EP0960120A1 (fr) 1999-12-01
JP2000513212A (ja) 2000-10-10
AU3117597A (en) 1997-11-26
EP0915904A1 (fr) 1999-05-19
AU2996797A (en) 1997-11-26
WO1997042211A1 (fr) 1997-11-13
EP0915904A4 (fr) 2001-05-02
JP2000510693A (ja) 2000-08-22

Similar Documents

Publication Publication Date Title
HUP0100436A3 (en) Mammalian cytokine-like polypeptide-10
GB9619133D0 (en) An electrolyte
AP9801334A0 (en) Ther peuti comb natio
PL332960A1 (en) Novel agonists of erythropoietin
AU4243097A (en) Mammalian chemokines, related reagents
AU3347295A (en) Substituted pyrimidine(thi)ones
GB9701710D0 (en) Mammalian protein
IL143052A0 (en) Mammalian chondromodulin-like protein
AU2996797A (en) Mammalian sex comb on midleg (mammalian (scm)) acts as an oncogene
EP0960115A4 (fr) GENE MAMMALIEN Asx AGISSANT COMME ONCOGENE
GB9709215D0 (en) Electrochemical process
GB9707922D0 (en) Stabilized isothioazolone solution
AU7410398A (en) Identifying mammalian genes
GB9708412D0 (en) An umbrella
ZA9811810B (en) Mammalian circadian regulator m-rigui2 (m-per2).
GB9620647D0 (en) Block with no fixed attachment point
AU7815091A (en) Sub-panel clip
AU1773897A (en) Animal holder
GB9418821D0 (en) Ovulation predictor
GB2310122B (en) Cane holder
AP9600848A0 (en) Ther peuti amid s
HK1026716A (en) Mammalian cytokine-like polypeptide-10
AUPO259496A0 (en) Ducted delights
HU0400360D0 (en) Set for autolog transplantation
GB9623621D0 (en) Low temperature coatings

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981127

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/12 A, 7C 12N 15/63 B, 7C 07K 14/47 B, 7C 07K 16/18 B, 7A 61K 31/70 B, 7A 61K 39/00 B, 7G 01N 33/53 B

A4 Supplementary search report drawn up and despatched

Effective date: 20010319

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021203